CJC-1295 + Ipamorelin Blend 10mg (5mg / 5mg)
Welcome to the official VitalisLabs UK product page for our dual-action CJC-1295 + Ipamorelin 10mg blend. Co-lyophilized in an exact 1:1 mass ratio (5mg CJC-1295 without DAC / 5mg Ipamorelin), this formulation allows researchers to evaluate dual-receptor growth hormone secretagogue (GHS) pathways simultaneously in a single, high-purity laboratory vial.
Buy CJC 1295 Ipamorelin 5mg/5mg UK — Analytical Grade Synergy
When studying pituitary GH pulse frequency and amplitude, maintaining precise constituent concentration ratios is essential. When you buy CJC 1295 Ipamorelin 5mg 5mg UK directly from VitalisLabs, each vial is freeze-dried under strict vacuum parameters to preserve individual sequence stability and prevent premature oxidation.
+-----------------------------------------------------------------------+
| PRODUCT SPECIFICATION OVERVIEW |
| |
| * Product Identifier: VL-CJCIPA-10 |
| * Total Content per Vial: 10mg total co-lyophilized blend |
| * Composition Breakdown: |
| - CJC-1295 (Without DAC / Mod GRF 1-29): 5mg |
| - Ipamorelin (GHRP / Ghrelin Receptor Agonist): 5mg |
| * Purity Level: >99.0% (HPLC & MS Verified per constituent) |
| * Physical Form: Freeze-Dried / Lyophilized White Powder |
| |
| [ Download Batch COA Certificate ] ---> Opens PDF |
+-----------------------------------------------------------------------+
Dual Mechanism of Action: Synergy Explained
Combining CJC-1295 without DAC (Mod GRF 1-29) with Ipamorelin creates a dual-pathway secretagogue model targeting two distinct receptor families on pituitary somatotrophs:
-
GHRH Receptor Binding (CJC-1295 5mg): Functions as a Growth Hormone-Releasing Hormone (GHRH) analog, binding to the GHRH receptor to stimulate adenylate cyclase and initiate growth hormone synthesis.
-
Ghrelin/GHS Receptor Agonism (Ipamorelin 5mg): Acts as a selective Growth Hormone Secretagogue Receptor (GHSR-1a) agonist, signaling through intracellular calcium release to trigger immediate GH vesicle secretion.
-
Synergistic Secretion Pulse: Simultaneous activation of both GHRHR and GHSR-1a yields a physiological pulse response greater than the additive sum of either peptide administered in isolation.
CJC-1295 with DAC vs. Without DAC (Mod GRF 1-29)
A vital distinction in growth hormone secretagogue research involves the presence of Drug Affinity Complex (DAC):
| Parameter | CJC-1295 Without DAC (In this 5/5mg Blend) | CJC-1295 With DAC |
| Structure | Tetrasubstituted 29-amino-acid peptide (Mod GRF 1-29) | Mod GRF 1-29 + Lys-maleimidopropionyl complex |
| Half-Life | ~30 minutes (Pulsatile response model) | ~6 to 8 days (Continuous elevation model) |
| Primary In Vitro Purpose | Mimicking physiological, natural episodic GH release pulses | Constant baseline endocrine receptor activation |
Technical Specifications: CJC-1295 + Ipamorelin 10mg
| Parameter | CJC-1295 (Without DAC) Component | Ipamorelin Component |
| Peptide Type | GHRH Analog (Mod GRF 1-29) | GH Secretagogue / Ghrelin Agonist |
| Amino Acid Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular Formula | $C_{152}H_{252}N_{44}O_{42}$ | $C_{38}H_{49}N_{9}O_{5}$ |
| Molecular Weight | ~3367.9 g/mol | ~711.86 g/mol |
| Mass Share | 5mg per vial | 5mg per vial |
Reconstitution & Handling Guidelines
-
Lyophilized Storage: Store unopened vials in a dry freezer at -20°C away from light.
-
Reconstitution Volume: Reconstitute with sterile bacteriostatic water or laboratory saline diluent.
-
Handling Note: Direct fluid gently along the vial wall. Allow the cake to dissolve fully without shaking to prevent shearing of the peptide chains.
-
Post-Reconstitution Storage: Keep reconstituted solutions refrigerated at 2°C to 8°C.
Compliance Disclaimer: All buy research peptides CJC Ipamorelin UK products provided by VitalisLabs are strictly intended for laboratory in vitro evaluation, chemical assay, and scientific research. They are not intended for human consumption, clinical usage, or therapeutic administration.






Reviews
There are no reviews yet.